Comparon IVS: Financial statements 2017
CVR: 37794414
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Comparon IVS (CVR 37794414) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -4,875. Equity in the 2017 report amounted to DKK 126. The solvency ratio was 100%.
- Profit/Loss
- DKK -4,875
- Equity
- DKK 126
- Total Assets
- DKK 126
Official annual report
Keep an eye on Comparon IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Comparon IVS has published its interim report for the period June 13, 2016 – December 31, 2016.
As of October 3, 2017, Andreas Casper Christensen Linde has joined the board of directors of Comparon IVS.
As of October 3, 2017, Stefan Vinding Olesen has joined the board of directors of Comparon IVS.
As of October 3, 2017, Andreas Casper Christensen Linde is registered as director of Comparon IVS.
As of October 3, 2017, Stefan Vinding Olesen is registered as director of Comparon IVS.
As of October 3, 2017, Henrik Løvig Jensen is registered as chairman of Comparon IVS.
As of August 31, 2017, Andreas Casper Christensen Linde has left the board of directors of Comparon IVS.
As of August 31, 2017, Stefan Vinding Olesen has left the board of directors of Comparon IVS.
As of August 31, 2017, Anders Hyldborg has left the board of directors of Comparon IVS.
As of August 31, 2017, Andreas Casper Christensen Linde has stepped down as director of Comparon IVS.
About Comparon IVS
Comparon IVS was a Danish company of the type Iværksætterselskab based in Aarhus N, founded in 2016. The company has been dissolved on 15 November 2018. The company was registered under the industry Webportaler. In 2017, the company reported a net result of DKK -4,875. Equity in the 2017 report amounted to DKK 126.